Health

Qatar Investment Authority, Abbott and global icons fuel WHOOP’s $10.1B healthtech leap

WHOOP has secured a massive $575 million funding round at a $10.1 billion valuation, signaling a bold shift from fitness tracking to predictive healthcare.

WASHINGTON : The funding round, led by Collaborative Fund, saw participation from major institutional players including Qatar Investment Authority (QIA), Mubadala Investment Company, and healthcare giant Abbott, alongside global sports icons Cristiano Ronaldo and LeBron James. The scale of investment highlights growing confidence in WHOOP’s long-term ambition to transform healthcare through data-driven insights.

At the core of WHOOP’s strategy is a move beyond performance tracking toward predicting serious health events, such as heart attacks, before they occur. CEO Will Ahmed has outlined a vision of building a platform that shifts healthcare from reactive treatment to proactive prevention.

The company’s financial model is driven by subscriptions rather than hardware sales. With annual plans ranging between $200 and $360, WHOOP has built a strong recurring revenue engine. The platform has already demonstrated rapid growth, with bookings rising over 100% year-on-year in 2025 and an impressive 83% of users engaging with the app daily—an indicator of high user retention and habit formation.

The new capital will be deployed toward research and development, global expansion, and hiring, with over 600 new roles expected to support its next phase. WHOOP is also working closely with medical and regulatory bodies, including collaborations with institutions like Mayo Clinic, to gain credibility and approval for clinical-grade insights.

However, the transition into healthcare comes with significant challenges. Regulatory scrutiny remains a key hurdle, with authorities such as the U.S. Food and Drug Administration previously questioning certain features, including blood pressure insights, over concerns of crossing into medical diagnosis territory.

While WHOOP’s strong association with elite athletes has helped build brand credibility, scaling its offerings to a broader consumer base remains a critical test. The company must now translate its high-performance appeal into a compelling value proposition for everyday users seeking preventive healthcare solutions.

In terms of competition, WHOOP is not directly targeting mainstream smartwatches like Apple Watch. Instead, it is carving out a distinct space focused on continuous, in-depth health monitoring without distractions such as screens or notifications. This positions the device less as a lifestyle accessory and more as a dedicated health tool.

Positioning itself apart from mainstream smartwatches, WHOOP is building a screen-free, subscription-driven health device focused on deep, continuous monitoring. Its new capital will support regulatory engagement, clinical collaborations, and scaling beyond its athletic core. Success will hinge on navigating medical oversight while proving its value as a preventive health solution for a broader audience.

Majority of Premier League fans reject VAR, survey reveals

Rajasthan Royals sold for $1.63 Billion in IPL’s biggest-ever deal

Iran pushes to shift FIFA World Cup matches from U.S. to Mexico amid security fears

BCCI announces ₹131 crore reward as India clinch historic third T20 World Cup title

FIFA unveils ambitious plan of $75 million to rebuild Gaza’s football infrastructure